Vitamin D Testing Market Report 2026

The vitamin d testing market size has grown strongly in recent years. It will grow from $1 billion in 2025 to $1.1 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to rising prevalence of vitamin d deficiency, expansion of diagnostic laboratory networks, increasing awareness of bone health, adoption of standardized testing protocols, growth in clinical testing volumes.

The vitamin d testing market size is expected to see strong growth in the next few years. It will grow to $1.56 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for preventive healthcare diagnostics, expansion of home-based testing solutions, rising use of advanced analytical techniques, growing focus on personalized nutrition assessment, increased testing in aging populations. Major trends in the forecast period include increasing adoption of automated vitamin d assays, rising use of high-precision lc-ms techniques, expansion of preventive health screening programs, growing integration of laboratory information systems, enhanced focus on diagnostic accuracy.

The growing awareness of vitamin D deficiency is expected to drive the expansion of the vitamin D testing market in the coming years. Vitamin D deficiency occurs when the body has insufficient levels of vitamin D, leading to poor calcium absorption and resulting in weakened bones, muscle pain, and an increased risk of fractures. Contributing factors include limited sunlight exposure, increased use of sunscreen, inadequate dietary intake, and sedentary lifestyles. Vitamin D testing is essential to accurately assess and diagnose these deficiencies, enabling timely treatment and prevention of related health issues. For example, in July 2024, a survey of 1,400 participants conducted by Forth, a UK-based health and wellness company, found that 57% of individuals had vitamin D levels below the recommended range of 75-100 nmol/L, with an average level of 78.7 nmol/L. This growing awareness of deficiency disorders is therefore fueling demand for vitamin D testing.

Companies in the vitamin D testing market are developing innovative solutions, including vitamin D test kits, to enable convenient monitoring of vitamin D levels at home or in clinical settings. Vitamin D test kits are designed to measure blood levels of vitamin D, assisting in the assessment and management of deficiency, insufficiency, or excess. For instance, in August 2023, Biohit Oyj, a Finland-based diagnostics company, launched its Total 25OH Vitamin D ELISA kit. This quantitative immuno-enzymatic assay detects both 25-hydroxyvitamin D2 and D3 and is validated against the ID-LC/MS-MS reference measurement procedure. The kit, intended for clinical laboratory use, features a simplified six-step protocol, can be automated on standard ELISA platforms, and provides reliable assessments of vitamin D status.

In July 2024, Thyrocare Technologies Ltd., an India-based diagnostic and pathology service provider, acquired the pathology business of Polo Labs for an undisclosed amount. This acquisition strengthens Thyrocare’s diagnostic capabilities and expands its service portfolio by integrating Polo Labs’ network in North India. The combined infrastructure enhances service delivery, reduces turnaround times, and improves patient convenience. Polo Labs is an India-based company that provides vitamin D testing services, further supporting the growth of the vitamin D testing market.

Major companies operating in the vitamin d testing market are Siemens AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., F. Hoffmann-La Roche AG, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, bioMérieux SA, Tosoh Bioscience LLC, Revvity Inc., Quidel Corporation, Beckman Coulter Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Tecan Group Ltd., Randox Laboratories Ltd., Boditech Med Inc., Everlywell Inc., BioVendor Laboratorni medicina AS, Diazyme Laboratories Inc., DiaSys Diagnostic Systems GmbH, Qualigen Therapeutics Inc.

North America was the largest region in the vitamin D testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vitamin d testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vitamin d testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the vitamin D testing market by increasing costs of imported diagnostic reagents, assay kits, analytical instruments, mass spectrometry systems, and laboratory consumables. Diagnostic laboratories and hospitals in North America and Europe are most affected due to reliance on imported testing technologies, while Asia-Pacific faces cost pressures on equipment procurement. These tariffs are raising testing costs and affecting laboratory margins. However, they are also encouraging domestic reagent production, regional manufacturing of diagnostic equipment, and investment in localized laboratory supply chains.

The vitamin d testing market research report is one of a series of new reports that provides vitamin d testing market statistics, including vitamin d testing industry global market size, regional shares, competitors with a vitamin d testing market share, detailed vitamin d testing market segments, market trends and opportunities, and any further data you may need to thrive in the vitamin d testing industry. This vitamin d testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Vitamin D testing is a diagnostic process that measures the concentration of vitamin D in the blood to determine whether an individual has a deficiency or is at risk for related health problems. Vitamin D is vital for maintaining healthy bones and supporting immune function. The test typically measures 25-hydroxyvitamin D (25(OH)D), the most commonly used biomarker for assessing vitamin D status.

The main types of vitamin D testing include 25-hydroxy vitamin D testing, 1,25-dihydroxy vitamin D testing, and 24,25-dihydroxy vitamin D testing. 25-hydroxy vitamin D testing evaluates the level of calcidiol, the form of vitamin D produced when the body metabolizes vitamin D from sunlight or supplements. Various techniques are used, including radioimmunoassay (RIA), enzyme-linked immunosorbent assay (ELISA), high-performance liquid chromatography (HPLC), and liquid chromatography-mass spectrometry (LC-MS). These tests are applied for several indications such as osteoporosis, rickets, malabsorption, and general vitamin D deficiency. End users include hospitals, diagnostic laboratories, home care services, and point-of-care facilities, serving both clinical and research purposes.

The vitamin D testing market consists of revenues earned by entities by providing services such as consultation services, custom supplement recommendations, advanced metabolite testing and bone health assessments. The market value includes the value of related goods sold by the service provider or included within the service offering. The vitamin D testing market also includes sales of blood collection devices, test reagents and consumables, vitamin d test strips and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.